(ZY.2.06) Health Science

[New] Predicted to grow at a CAGR of 23.8% during the forecast period, the Global Regenerative Medicine Market is estimated to reach USD 38.7 billion by the end of 2024.
[New] Earlier this year, a McKinsey study revealed that by leaning on big data, as well as artificial intelligence and machine learning tools to process it, could lead to a potential $100 billion in annual savings for medicine and pharma.
There could be $100 billion in annual savings for medicine and pharma by leaning on big data as well as the artificial intelligence and machine learning tools to process it.
Global Regenerative Medicine Market valued approximately USD 49.68 billion in 2018 is anticipated to grow with a healthy growth rate of more than 24.2% over the forecast period 2019-2026.
Innovation producing breakthrough medicines and products will be more important than ever in the healthcare industry in the coming years.
The global sports medicine market is projected to reach a value of US$ 8.8 Billion by 2024, registering a CAGR of 6% during 2019-2024.
Global Regenerative Medicine Market valued approximately USD49.68 billion in 2018 is anticipated to grow with a healthy growth rate of more than 24.2% over the forecast period 2019-2026.
Recent trends in regenerative Medicine and its increasing applications will lead to an impressive market CAGR of 26.1% as a result of which the market will reach US$ 151,949.5 Mn by the end of 2026.
By 2050, people over age 65 will number over 1.6 billion, accounting for 20 percent of the global population - more than double the number today.
The global personalised medicine market, which includes personalised nutrition and wellness, is expected to be valued around US$2400 billion in 2022.
An international commission created by the US National Academy of Sciences, US National Academy of Medicine and the Royal Society of the United Kingdom is also preparing a framework to guide clinical research in germline gene editing, which is expected to be released in spring 2020.
The artificial intelligence in medicine market was valued at USD2.24 billion in 2018 and is projected to reach a value of USD17.02 billion by 2024, registering a CAGR of 40.15% during the forecast period, 2019-2024.
In terms of value, the Nuclear Medicine industry is expected to register a steady CAGR during the forecast period.
Australian 'health and wellness' products including functional foods, supplements and personalised nutrition, along with more sustainable products such as alternative protein, will become a AU$25bn billion market by 2030.
The global regenerative medicine market is competitive in nature and offer growth prospects, which are predicted to encourage several players to enter the market in the coming years.
Rates of LBW reduction worldwide will need to more than double to reach the annual rate of reduction of 2 · 74% required to meet the ambitious global nutrition target of 30% reduction of LBW by 2025.
By 2030, the Institute of Medicine projects an additional 3.5 million healthcare workers will be needed in the U.S., while the elderly population is expected to double by 2050.
Nutrition and food systems are a key area that FTA will explore in 2019 and the years to come.
The global Nuclear Medicine market is valued at US$4590 million in 2018 and will reach US$7580 million by the end of 2025, growing at a CAGR of 7.4% during 2019-2025.
The worldwide market for Regenerative Medicine is expected to grow at a CAGR of roughly 6.0% over the next five years, will reach US$260 million in 2024, from US$190 million in 2019.
The global mushroom market is projected to jump from $34.1 billion in 2015 to $69.3 billion by the end of 2024 amid growing consumer interest in functional foods and food as medicine.
Predicted to grow at a CAGR of 23.8% during the forecast period, the Global Regenerative Medicine Market is estimated to reach USD38.7 billion by the end of 2024.

See full forecast

Last updated: 15 February 2020